Media Availability: Researchers Identify Promising Therapy for Rare Immune Disorder

Media Availability: Researchers Identify Promising Therapy for Rare Immune Disorder

Thursday July 23, 2015

Promising Therapy for LRBA Deficiency

NIH researchers and their colleagues from Cincinnati Children’s Hospital have shown that the drug abatacept, which is FDA-approved for treating rheumatoid arthritis, may be a promising, long-term therapy for a rare immune disorder called LRBA deficiency.